• Journal of the Korean Society of Radiology
• /
• v.12 no.7
• /
• pp.807-812
• /
• 2018

In this study, we investigated the conditions used in setting the recommendation level of general radiography diagnostic reference and tried to evaluate the effective dose and biological evaluation using PCXMC v2.0 program. As a result based on the effective dose of male in ICRP 60, the highest Pelvis AP was 0.794 mSv. The lowest Chest PA was 0.050 mSv. In the case of ICRP 103, the highest T-Spine AP was 0.906 mSv The lowest Chest PA was 0.052 mSv. For 40 years old male and female adults, effective doses of general radiography were evaluated and even if the medical exposures are not subject to the limit of dose, efforts should be made to reduce the medical exposures of the people by keeping the dose below the recommended amount in order to minimize the probable effect of radiation hazard.

• Journal of the Korean Society of Radiology
• /
• v.15 no.7
• /
• pp.1041-1047
• /
• 2021

In this study, the effective dose for frequently general radiography among the diagnostic reference level (DRL) for examinations provided by the government in Korea was evaluated using the Monte Carlo N-Particle eXtended (MCNPX) simulation tool. We were selected to evaluate for a total of 5 examination sites which included head anterior-posterior, chest (posterior-anterior, lateral), abdomen anterior-posterior and pelvis anterior-posterior. Physical conditions such as tube voltage and tube current used in MCNPX simulation were used in domestic conditions of the Korea Disease Control and Prevention Agency (KDCA). To evaluate domestic medical radiation exposure, we used the HDRK-Man computerized human phantom manufactured based on the international standard ICRP 103 that was applied to the MCNPX simulation. The phantom could represent the standard body shape of Koreans. As a results, the effective dose corresponding to the DRL based on adult males of head anterior-posterior position was 0.086 mSv, chest posterior-anterior position was 0.05 mSv, chest lateral was 0.354 mSv, abdomen anterior-posterior position was 0.548 mSv, and pelvis anterior-posterior position was 0.451 mSv.

• Magazine of the Korea Institute for Structural Maintenance and Inspection
• /
• v.18 no.4
• /
• pp.2-8
• /
• 2014

본 고는 동절기 이후 무근 콘크리트의 상부에서 쉽게 발생하는 스케일링 현상에 주목하여 무근 콘크리트의 동해 발생원인을 고찰하고, 이에 대한 내구성을 향상시키기 위한 방안을 기존문헌조사를 통하여 1) 강도향상, 2) 진공배수공법 적용, 3) 흡수방지재 시공의 방법을 선정하였다. 그 후 각 방법의 동결융해저항성 향상 평가를 정량적으로 평가하기위하여 동결융해 시험을 통한 상대동탄성계수를 측정하였다. 그 결과 1), 2)번의 경우 동탄성계수가 약 15% 향상, 3)의 경우 강도에 따라 7~13%향상됨을 실험적으로 확인하였다. 따라서 상기의 방법 모두 무근 콘크리트의 동결융해 저항성 향상에 유효한 방법으로 판단되며, 이를 통해 무근콘크리트의 빈번히 발생하는 품질저하 및 이로인한 유지보수비용 절감을 도모할 수 있을 것으로 사료된다.

• Health Policy and Management
• /
• v.4 no.2
• /
• pp.126-147
• /
• 1994

Lyme 질환은 미국 코넷티컷주의 라임지방에서 관절염증상을 보이는 소아과환자에게서 1975년 처음 발견되었다, 사슴, 누루, 개 등에 기생하는 진드기에 의해 전염되며, 발병초기에는 감기증상을 수반한 황소의 눈과 비슷한 붉은 반점이 생긴다. 적기에 치료하지 않으면, 관절염, 심장질환, 안면신경마비 등으로 악화될 수 있다. 본 논문의 목적은 두가지로 나누어 볼 수 있다. 먼저, 진단초기의 Lyme질환과 관련된 의료 및 기타 경제적 비용을 저렴하게 계측할 수 있는 방법론을 개발하고 그 유효성을 검증하는 것이다. 둘째로 lyme질환의 비용에 대한 여러종류의 총괄적 계측치를 제공하고 발병의 위험요인을 색출하는 것이다. 본 논문에서는 차트분석이나 임상연구 등 고가의 비용이 수반되는 분석기법 대신에 Lyme질환 다발지역에 대한 설문조사를 실시하고 그 유효성을 재설문조사를 통해서 검증하는 방법을 사용하였다. 자료분석상의 난점은 조사대상자마다 응답하지 않은 항목(Missing Value)이 다르기 때문에, 총 비용을 계산할 때 모든 항목에 응답한 조사대상자만을 사용한다면 표본의 크기가 너무 작아지는 것이었다. 이에 대한 대안으로 총비용 및 부분별 비용의 합을 계산할 때 표본의 일부가 응답하지 않은 항목에 대해서는 그 항목에 응답한 나머지 조사대상자의 응답치 평균을 대체하는 방법을 사용하였다. 통계적 분석결과, 질환의 증상시작부터 설문조사시기까지 Lyme질환과 관련된 사회적 총비용은 US$ 6400으로 추정되었다. 이중에 200가량은 환자의 보호자와 관련된 비용이고 나머지는 환자와 관련되 것이다. 총의료비용의 평균은 계산방법에 따라서 US$ 3000-4200의 범위를 보였다. 응답되지 않은 항목을 해당항목에 대한 응답치평균으로 대체하였을 때 총의료비평균은 US$ 4108이었다. 시간비용을 생산성손실에 대한 사회적 가치와 실제임금 손실의 두가지 방법에 의해 계산되었다. 실제임금손실은 생산손실의 사회적 가치의 약 30%에 불과하였다. 본 논문의 결과는 의료비용 및 비용과 생산성손실에 대한 정보가 지역보건담당자에 의한 전화설문조사에 의해 경제적이고도 일관성 있게 수집될 수 있다는 근거로 해석될 수 있다.

• Proceedings of the IEEK Conference
• /
• 1998.10a
• /
• pp.899-902
• /
• 1998

임상진단에 있어서 종종 문제가 되고 있는 호흡에 따른 두뇌부분의 가상적인 상하이동을 고려해서 위상 엔코드 축인 Y 방향만의 강체의 평행이동을 취급한다. 종래의 발견적인 축차 근사 반복처리에 의한 제거방법과는 달리, 본 연구에서는 MRI 촬상과정과 화상특성의 해석에 근거한 MRI 신호중의 체동성분과 화상성분을 단순한 대수연산에 의해 분리할 수 있는 새로운 구속조건을 도출한다. MRI 신호에 대해서 X 방향의 1차원 푸리에 변환을 행한 후의 Y 방향의 스펙트럼 위상값은 화상자신의 성분과 체동성분의 합이 되고 있다. 한편, 두뇌부위 등의 단층상에 있어서 주위의 피하지방 부분의 밀도는 거의 균일한 것 알려져 있어 이 부분위의 Y 방향의 1 라인 밀도분포를 대칭이라고 간주할 수 있다. 밀도함수가 대칭인 경우 스펙트럼의 위상은 그 위치에 대하여 선형적으로 변화한다. 따라서 이 선형함수로부터 벗어난 성분을 체동성분으로 분리할 수 있다. 이러한 구속조건에 기초를 둔 근거가 명확한 아티팩트의 제거방법을 제안한다. 아울러 본 방법의 유효성을 확인하기 위해 호흡에 의한 주기성의 체동을 가진 MRI 화상에 대해서 시뮬레이션을 행하였다.

• Journal of the Korea institute for structural maintenance and inspection
• /
• v.15 no.5
• /
• pp.101-112
• /
• 2011

This paper shows a study carried out on the estimation of nominal flexural strength for CFRP-plated RC beams failed by intermediate crack debonding. A strength reduction factor is proposed to consider the effect of the intermediate crack debonding for the determination of nominal flexural strength. The proposed factor is derived from experimental data and utilizes the ratio of effective stress(or strain) in the CFRP plate to its ultimate strength(or strain) which is called effective strain model. An analytical equation for the estimation of the nominal flexural strength is formulated as a function of strength reduction factor. The validity, accuracy and efficiency of the proposed factor are established by comparing the analytical results with the experimental data, and the major design codes, as well as a number of factors given by researchers. The analytical results presented in this paper indicate that the proposed factor can effectively estimate the flexural nominal strength of CFRP-plated reinforced concrete beams failed by intermediate crack debonding.

• The KIPS Transactions:PartB
• /
• v.15B no.2
• /
• pp.137-146
• /
• 2008

Fault localization plays a significant role in enormous distributed system because it can identify root cause of observed faults automatically, supporting self-managing which remains an open topic in managing and controlling complex distributed systems to improve system reliability. Although many Artificial Intelligent techniques have been introduced in support of fault localization in recent research especially in increasing complex ubiquitous environment, the provided functions such as diagnosis and prediction are limited. In this paper, we propose fault localization for self-managing in performance evaluation in order to improve system reliability via learning and analyzing real-time streams of system performance events. We use probabilistic reasoning functions based on the basic Bayes' rule to provide effective mechanism for managing and evaluating system performance parameters automatically, and hence the system reliability is improved. Moreover, due to large number of considered factors in diverse and complex fault reasoning domains, we develop an efficient method which extracts relevant parameters having high relationships with observing problems and ranks them orderly. The selected node ordering lists will be used in network modeling, and hence improving learning efficiency. Using the approach enables us to diagnose the most probable causal factor with responsibility for the underlying performance problems and predict system situation to avoid potential abnormities via posting treatments or pretreatments respectively. The experimental application of system performance analysis by using the proposed approach and various estimations on efficiency and accuracy show that the availability of the proposed approach in performance evaluation domain is optimistic.

• Journal of the Korea Institute of Information and Communication Engineering
• /
• v.5 no.4
• /
• pp.829-840
• /
• 2001

In this study, we propose a method for quantifying the degree of advance of pulmonary emphysema by using chest X-ray images. With this method, we devise two schemes for this purpose. One is for detecting blood vessels by using a deformable model with the tree-like structure and using an evaluation function specialized by knowledge about blood vessels appeared in chest X-ray images, and the other is for quantifying the degree of advance by using several features, which were extracted from blood vessels, and the equation of quantitative evaluation. In order to evaluate the performance, we applied the proposed method to 189 ROIs(Regions of Interest) of ten chest X-ray images and compared the values by the proposed method with those by a medical doctor.

• Journal of Chest Surgery
• /
• v.34 no.7
• /
• pp.539-546
• /
• 2001

Background: Pulmonary complications in immunocompromised patients are often fatal. Empirical treatment is usually applied based on the clinical and radiological findings because of the risk of the aggressive diagnostic procedures such as open lung biopsy. However, recent advancements in operative procedures and perioperative management has decreased the procedure-related risks. We have prospectively analyzed the risks and benefits of the early application of open lung biopsy in such patients. Material and Method: Forty-two consecutive immunocompromised patients with critical pulmonary complications were included from June, 1996 to December, 1999. The definition of the immunocompromised is as those with chemotherapy and/or other modality for hematologic disorders, with usage of immunosuppressive drug after transplantation, with usage of steroid for more than 1 month, and with primary immunodeficiency disorders. The indication of open lung biopsy was those with no significant improvement after a week of aggressive application of empirical treatment or with rapidly aggressive process. The underlying disease included hematologic disorder(31 patients), post-transplantation(3 patients), chemotherapy for solid tumor(2 patients), and others(6 patients). Operations were done through thoracotomy(conventional or mini-) or VATS.

• Journal of Genetic Medicine
• /
• v.8 no.1
• /
• pp.28-34
• /
• 2011

Most clinicians understand clinical trials as the evaluation process for new medicine before their use. However, clinical trials can also be applied to laboratory diagnostic tests (LDTs) to verify diagnostic accuracy and efficacy before their clinical laboratory implementation for patients. The clinical trial of LDT has two distinctive characteristics that are different from the case of pharmaceuticals and thus worth special consideration. One of them is the level of evidence. The well-designed randomized controlled trials (RCTs) are known to provide the best evidence to prove the clinical efficacy of any pharmaceutical products. However, RCTs lose practicality when applied to LDTs due to various issues including ethical complications. For this reason, comparative study format is considered more feasible approach for LDTs. In addition pharmaceuticals and LDTs are different in that the user's intervention is not required for the former but critical to the latter. Moreover, in the case of pharmaceuticals, end-products are produced by manufacturers before being used by clinicians. However, in LDTs, once reagents and instruments are provided by manufacturers, they are first utilized by clinical laboratories to produce test results in order for clinicians to use them later. In other words, when it comes to LDTs, clinical laboratories play the role of manufacturers, providing reliable test results with improved quality assurance. Considering the distinctive characteristics of LDTs, we would like to offer detailed suggestions to successfully perform clinical trials in LDTs, which include analytical performance measures, clinical test performance measures, diagnostic test accuracy measures, clinical effectiveness measures, and post-implementation surveillance.